Posted by & filed under Compliance, Featured.

By Dr. Candace DeLapp

Senate Bill 22 (SB18-22): Clinical Practice for Opioid Prescribing was signed in to law May 2018.

Briefly, its impact on the practice of Dentistry is:

Initial prescription must be limited to a seven-day supply if the prescriber has not written an opioid prescription for the patient in the last 12 months.

The limits on initial prescribing do not apply if, in the judgement of the dentist, the patient:

  • has chronic pain that lasts longer than 90 days or past the time of normal healing, as determined by the dentist, or following transfer of care from another dentist who prescribed an opioid for the patient;
  • has been diagnosed with cancer and is experiencing cancer-related pain; or
  • is experiencing post-surgical pain that, because of the nature of the procedure, is expected to last more than fourteen days.

The prescriber may exercise discretion for a second seven-day prescription.

The prescriber must check the Prescription Drug Monitoring Program (PDMP) database except under specific requirements:

  • the patient is experiencing post-surgical pain which routinely exceeds 14 days;
  • the patient has cancer or cancer-related pain;
  • the prescription is administered by an in-patient facility
  • the patient is in hospice or palliative care

For more information on opioid prescribing contact The Trust:

Dr. Kluender [email protected]

Dr. DeLapp [email protected]

Or read the bill here.

[email protected]